Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01722162
Title Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

colorectal cancer

Therapies

Bevacizumab + Capecitabine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine St. Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field